AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $612,078 | -1.1% | 262,694 | +1.0% | 0.07% | -25.3% |
| Q2 2023 | $619,006 | +29.3% | 260,087 | 0.0% | 0.10% | -9.2% |
| Q1 2023 | $478,559 | -3.2% | 260,087 | 0.0% | 0.11% | -8.4% |
| Q4 2022 | $494,166 | -11.1% | 260,087 | 0.0% | 0.12% | +7.2% |
| Q3 2022 | $556,000 | -39.0% | 260,087 | -19.3% | 0.11% | -33.1% |
| Q2 2022 | $912,000 | -41.2% | 322,217 | -13.4% | 0.17% | -18.6% |
| Q1 2022 | $1,552,000 | -45.1% | 372,217 | -31.7% | 0.20% | -51.5% |
| Q4 2021 | $2,827,000 | -20.8% | 544,819 | 0.0% | 0.42% | +67.7% |
| Q3 2021 | $3,568,000 | -60.4% | 544,819 | -59.8% | 0.25% | -65.5% |
| Q2 2021 | $9,004,000 | +25.1% | 1,356,048 | +8.0% | 0.73% | +200.8% |
| Q1 2021 | $7,196,000 | – | 1,256,048 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |